Cabaletta Bio (CABA) Total Current Liabilities (2018 - 2025)

Cabaletta Bio has reported Total Current Liabilities for 8 years, with the latest figure at $50.2 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 85.16% year-over-year to $50.2 million; the trailing twelve-month figure through Dec 2025 stood at $50.2 million (up 85.16% YoY), and the FY2025 full-year result was $50.2 million, up 85.16% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $50.2 million, up from $45.7 million in the prior quarter.
• The five-year high for Total Current Liabilities was $50.2 million in Q4 2025, with the low at $4.0 million in Q1 2021.
• Average Total Current Liabilities over 5 years is $17.7 million, with a median of $10.1 million recorded in 2022.
• Year-over-year, Total Current Liabilities retreated 3.69% in 2022 and jumped 132.08% in 2025.
• Tracing CABA's Total Current Liabilities over 5 years: stood at $8.4 million in 2021, then increased by 13.23% to $9.5 million in 2022, then soared by 68.55% to $16.0 million in 2023, then soared by 69.35% to $27.1 million in 2024, then surged by 85.16% to $50.2 million in 2025.
• The last three Total Current Liabilities figures came in at $50.2 million (Q4 2025), $45.7 million (Q3 2025), and $41.5 million (Q2 2025), per Business Quant data.

Peer Comparison